https://www.selleckchem.com/pr....oducts/gsk3326595-ep
BACKGROUND India accounts for quarter of global rifampin-resistant/multi-drug resistant-tuberculosis (RR/MDR-T. Knowledge on risk-factors and distribution of MDR-TB at district level is limited. OBJECTIVE Study prevalence and risk factors of MDR-TB in tuberculosis patients in hilly districts of Himachal Pradesh, India. METHODS Between July 2012-June 2013, TB patients registered under the Revised National Tuberculosis Control Program in Kangra and Una districts suspected of MDR-TB were referred for Xpert® MTB/RIF testing a
Like
Comment
Share
